Leukemia drug Ponatinib shrinks hypertrophic heart cells in early lab test
A new study combining network pharmacology, molecular docking, and H9C2 cell experiments found that low-dose Ponatinib significantly reduced high-salt-induced hypertrophy ...
A new study combining network pharmacology, molecular docking, and H9C2 cell experiments found that low-dose Ponatinib significantly reduced high-salt-induced hypertrophy ...
A cell study finds teriflunomide suppresses growth signalling in luminal breast cancer cells while triple-negative cells show adaptive kinase rewiring.
A large observational study in Israeli and US health records found that exposure to the antimalarial drugs atovaquone-proguanil and mefloquine, ...
A systematic review and meta-analysis confirms that hydroxychloroquine, chloroquine, ivermectin, azithromycin and doxycycline lack clinically meaningful efficacy against COVID-19, and ...
A screen of about 2,600 approved drugs identified the phospholipase A2 inhibitor darapladib as a potent, resistance-resistant antifungal candidate against ...
A UK Biobank study of 47,537 people identified 213 plasma proteins linked to rheumatoid arthritis onset and built a deep ...
A new study reports that the approved leukemia drug nilotinib binds the DNA repair protein NEIL3 to block fatty acid ...
A 346-publication analysis finds rapidly expanding research on SGLT2 inhibitors across cancer safety, antitumor mechanisms, real-world outcomes and cardio-oncology, but ...
In a rat model of paraquat-induced kidney damage, the approved drug disulfiram reduced tissue injury, fibrosis, and oxidative stress, with ...
An international team led by RCSI and The Institute of Cancer Research, London, used an AI tool called iPhenMap to ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine